Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
M170823-100mg
|
100mg |
1
|
$54.90
|
|
|
M170823-1g
|
1g |
≥10
|
$487.90
|
|
|
M170823-5g
|
5g |
5
|
$2,193.90
|
|
|
M170823-10g
|
10g |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$3,947.90
|
|
|
M170823-25g
|
25g |
5
|
$8,881.90
|
|
|
M170823-100g
|
100g |
2
|
$31,975.90
|
|
| Synonyms | 5317-33-9 | 1-(3-Hydroxypropyl)-4-methylpiperazine | 3-(4-methylpiperazin-1-yl)propan-1-ol | 4-Methyl-1-piperazinepropanol | 1-Piperazinepropanol, 4-methyl- | 3-(4-Methyl-1-piperazine)propan-1-ol | MFCD00009781 | 3-(n-methylpiperazine)-propanol | NSC-351986 | NSC-79874 | EIN |
|---|---|
| Specifications & Purity | ≥98% |
| Storage Temp | Room temperature |
| Shipped In | Normal |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Diazinanes |
| Subclass | Piperazines |
| Intermediate Tree Nodes | N-alkylpiperazines |
| Direct Parent | N-methylpiperazines |
| Alternative Parents | 1,3-aminoalcohols Trialkylamines Azacyclic compounds Primary alcohols Organopnictogen compounds Hydrocarbon derivatives |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | N-methylpiperazine - 1,3-aminoalcohol - Tertiary amine - Tertiary aliphatic amine - Alkanolamine - Azacycle - Organic nitrogen compound - Hydrocarbon derivative - Organopnictogen compound - Primary alcohol - Organooxygen compound - Organonitrogen compound - Amine - Organic oxygen compound - Alcohol - Aliphatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as n-methylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries a methyl group. |
| External Descriptors | Not available |
|
|
|
| Pubchem Sid | 488185691 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488185691 |
| IUPAC Name | 3-(4-methylpiperazin-1-yl)propan-1-ol |
| INCHI | InChI=1S/C8H18N2O/c1-9-4-6-10(7-5-9)3-2-8-11/h11H,2-8H2,1H3 |
| InChIKey | JKRSQNBRNIYETC-UHFFFAOYSA-N |
| Smiles | CN1CCN(CC1)CCCO |
| Isomeric SMILES | CN1CCN(CC1)CCCO |
| WGK Germany | 3 |
| Molecular Weight | 158.24 |
| Reaxy-Rn | 105979 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=105979&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Dec 19, 2023 | M170823 | |
| Certificate of Analysis | Apr 12, 2023 | M170823 | |
| Certificate of Analysis | Apr 12, 2023 | M170823 | |
| Certificate of Analysis | Apr 12, 2023 | M170823 | |
| Certificate of Analysis | Apr 12, 2023 | M170823 | |
| Certificate of Analysis | Sep 01, 2022 | M170823 | |
| Certificate of Analysis | Sep 01, 2022 | M170823 | |
| Certificate of Analysis | Sep 01, 2022 | M170823 | |
| Certificate of Analysis | Sep 01, 2022 | M170823 |
| Molecular Weight | 158.240 g/mol |
|---|---|
| XLogP3 | -0.300 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 158.142 Da |
| Monoisotopic Mass | 158.142 Da |
| Topological Polar Surface Area | 26.700 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 100.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
| 1. Yingli Wang, Jiang Yu, Dan Li, Liwen Zhao, Bingjun Sun, Jiamei Wang, Zhenjie Wang, Shuang Zhou, Menglin Wang, Yinxian Yang, Hongzhuo Liu, Haotian Zhang, Qingzhi Lv, Qikun Jiang, Zhonggui He, Yongjun Wang. (2022) Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy. JOURNAL OF CONTROLLED RELEASE, 341 (812). |